GlaxoSmithKline, one of the world’s largest pharmaceutical companies, is in the midst of a fascinating digital transformation. To accelerate their process, they recently created a new chief digital and technology officer role, and brought on the former CIO of Walmart to fill it. They have been active in applying AI to drug discovery and clinical trials, have sought to use inhalers with clip-on sensors to combat asthma, and have deployed their first medical device mobile app. To get some detail on what was going on behind the scenes of their transformation, I spoke with Adam Raeburn-James, SVP End User and Infrastructure Services and Business Service Centers.